|
|||||||
|
|||||||
|
|||||||
Stage 2019: Metal-complexes of modified indolo[2,3-c]quinolines and new indolo[3,2- d]benzazepines
Specific aims: Deliverables: Stage 2019: At least four well-defined metal complexes based on new indolo[2,3-c]quinolines and indolo[3,2-d]benazepines containing metal-binding sites; results of antiproliferative activity assays for four proligands and four metal complexes; at least one research article submitted at an ISI journal; Scientific Report.
|
![]()
|
||||||
|